Analytics 4 Life, founded in Toronto, is a medical technology startup rethinking how we diagnose and image cardiac disease using AI. Initially focused on coronary artery disease and pulmonary hypertension, the company has now raised about $29 million across three rounds, has three offices around the world, and is growing quickly. With a radiation-free system, the company provides point of care results for cardiac diagnoses.
Analytics 4 Life was recently granted two patents and had another application published, bringing their count to 6 issued and 18 total documents in the AI Biotech sector. Their recently issued patents teach analysis of a biopotential signal collected from a single electrode with machine learning in order to create a multi-dimensional phase-space representation of the heart. This information is useful in diagnosing some pathologies.
Announced in June, the company is one of the first companies involved in Johnson & Johnson's JLabs @ Shanghai. This location is the world's largest JLabs yet and can support over 50 life sciences startups across medical device, pharmaceutical, consumer, and health tech segments.
Artificial intelligence and human health don’t stop with our general diagnostics, cardiology, neurology, and activity sectors. This sector covers AI/ML-centric advancements in auditory, dental, GI/hepatic, circulatory, immune, musculoskeletal, ocular, reproductive, respiratory, dermatological, urinary, rectal, and spectrometry related biotech.
View Patent Forecast®
Top Corporations
News and Insights
Data Visualization
Artificial intelligence and human health don’t stop with our general diagnostics, cardiology, neurology, and activity sectors. This sector covers AI/ML-centric advancements in auditory, dental, GI/hepatic, circulatory, immune, musculoskeletal, ocular, reproductive, respiratory, dermatological, urinary, rectal, and spectrometry related biotech.